Pharmasyntez

The company manufactures a broad range of medicines in key therapeutic areas, including antiviral and antibacterial medicines, as well as treatments for tuberculosis, neuropsychiatric and cardiovascular diseases

170+
medicines in production
1997
company established in Irkutsk
33%
of packs of anti-tuberculosis and antiretroviral medicines in Russia are manufactured by Pharmasyntez

Management

Strategic management of the company

Alexander Yuryevich Shikhanov

General Director

Developing original medicines in Russia makes an important contribution to import substitution and strengthens the country’s technological sovereignty. I am confident that it is here in Irkutsk that young professionals will be able to fulfil their potential by working on research-intensive projects.

Pharmasyntez

Therapeutic expertise

Providing access to advanced medicines in key therapeutic areas

company portfolio

17
production lines
40 mil
packs per year
3 mil
tablets produced daily by a single production area at the plant

Manufacturing capabilities

Pharmasyntez Group’s first and largest plant, with an R&D centre

001
Manufacturing technologies
Pharmasyntez Group’s first and largest plant, with an R&D centre
002
Company infrastructure
More than 40,000 m² of manufacturing, laboratory and logistics space
003
Scientific development
Development of complex formulations and finished dosage forms for cardiology, neurology, infectious disease treatment and pain relief
004
A range of dosage forms
Manufacturing tablets, capsules, granules, solutions, suspensions, sterile powders, lyophilisates and suppositories